Flagship Harbor Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,148
| Closed | -$47K | – | 559 |
|
|
2020
Q3 | $47K | Buy |
1,148
+14
| +1% | +$573 | 0.01% | 869 |
|
|
2020
Q2 | $54K | Hold |
1,134
| – | – | 0.01% | 831 |
|
|
2020
Q1 | $48K | Hold |
1,134
| – | – | 0.01% | 760 |
|
|
2019
Q4 | $49K | Hold |
1,134
| – | – | 0.01% | 807 |
|
|
2019
Q3 | $40K | Hold |
1,134
| – | – | 0.01% | 838 |
|
|
2019
Q2 | $30K | Sell |
1,134
-7,000
| -86% | -$185K | 0.01% | 916 |
|
|
2019
Q1 | $218K | Hold |
8,134
| – | – | 0.04% | 380 |
|
|
2018
Q4 | $131K | Sell |
8,134
-3,000
| -27% | -$48.3K | 0.03% | 459 |
|
|
2018
Q3 | $231K | Sell |
11,134
-650
| -6% | -$13.5K | 0.04% | 378 |
|
|
2018
Q2 | $179K | Buy |
+11,784
| New | +$179K | 0.04% | 426 |
|
|
2017
Q4 | – | Sell |
-6,884
| Closed | -$260K | – | 369 |
|
|
2017
Q3 | $260K | Buy |
+6,884
| New | +$260K | 0.08% | 265 |
|
|
2017
Q2 | – | Sell |
-6,234
| Closed | -$202K | – | 344 |
|
|
2017
Q1 | $202K | Buy |
+6,234
| New | +$202K | 0.08% | 300 |
|